[{"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-001", "question": "A 5-month-old infant presents with exaggerated startle response to noise, progressive motor regression, and bilateral macular cherry-red spots. Serum hexosaminidase A and B levels are within normal limits. Genetic sequencing reveals a mutation in the GM2A gene. Which of the following is the correct diagnosis?", "options": ["Tay-Sachs disease", "Sandhoff disease", "GM2 activator deficiency", "Sialidosis type I", "Niemann-Pick disease type A"], "answer": "C", "answer_index": 2, "explanation": "The clinical phenotype mimics Tay-Sachs (Hex A deficiency) and Sandhoff (Hex A and B deficiency) diseases, including the cherry-red spot and startle response. However, normal enzyme levels with a mutation in GM2A indicate the AB variant of GM2 gangliosidosis, caused by a deficiency in the GM2 activator protein required for the interaction between the lipid substrate and the enzyme.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "C", "model_outputs": "Based on the clinical presentation and laboratory findings, the patient has GM2 activator deficiency (also known as the AB variant of GM2 gangliosidosis).\n\n1.  Clinical Presentation: The infant presents with classic symptoms of infantile GM2 gangliosidosis, including an exaggerated startle response to noise (hyperacusis), progressive motor regression, and bilateral macular cherry-red spots. These features are indistinguishable from Tay-Sachs disease and Sandhoff disease.\n2.  Enzyme Levels: The key differentiator here is the enzymatic profile.\n    *   Tay-Sachs disease (Option A) is caused by a deficiency of hexosaminidase A (due to *HEXA* mutations).\n    *   Sandhoff disease (Option B) is caused by a deficiency of both hexosaminidase A and B (due to *HEXB* mutations).\n    *   The vignette states that serum hexosaminidase A and B levels are normal. This rules out both Tay-Sachs and Sandhoff diseases.\n3.  Genetics: The presence of a mutation in the GM2A gene confirms the diagnosis. The *GM2A* gene encodes the GM2 activator protein, a cofactor required for hexosaminidase A to degrade GM2 ganglioside in vivo. When this protein is deficient, GM2 ganglioside accumulates despite normal levels of the hexosaminidase A enzyme in vitro assays (which use artificial substrates that do not require the activator protein).\n4.  Other Options:\n    *   Sialidosis type I (Option D) involves a deficiency of alpha-N-acetyl neuraminidase (sialidase) and is associated with the *NEU1* gene.\n    *   Niemann-Pick disease type A (Option E) is caused by acid sphingomyelinase deficiency (*SMPD1* gene) and typically presents with hepatosplenomegaly, which is usually absent in Tay-Sachs and GM2 activator deficiency.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-002", "question": "A 24-year-old African American male presents with cyanosis and shortness of breath after taking dapsone for a skin lesion. Pulse oximetry reads 85% and does not improve with supplemental oxygen. Arterial blood gas shows a normal PaO2 but methemoglobin level is 18%. He has a known history of hemolysis after ingesting fava beans. Which of the following is the most appropriate treatment?", "options": ["Methylene Blue 1 mg/kg IV", "Ascorbic Acid (Vitamin C) IV", "Hydroxocobalamin IV", "Hyperbaric Oxygen Therapy", "Sodium Thiosulfate IV"], "answer": "B", "answer_index": 1, "explanation": "The patient has methemoglobinemia precipitated by dapsone. However, his history of hemolysis with fava beans strongly suggests Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Methylene blue is contraindicated in G6PD deficiency because it requires NADPH (generated by G6PD) to reduce methemoglobin; without G6PD, methylene blue is ineffective and can induce severe hemolysis. Ascorbic acid (Vitamin C) or exchange transfusion is the appropriate management.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "The clinical scenario describes a patient with acquired methemoglobinemia (precipitated by dapsone) who also has a history suggestive of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency (African American male, history of hemolysis with fava beans).\n\n1.  Diagnosis: Dapsone is a hydroxylamine that causes oxidative stress, leading to the oxidation of ferrous iron (Fe2+) in hemoglobin to ferric iron (Fe3+), creating methemoglobin. This results in functional anemia and a left shift of the oxygen dissociation curve. The pulse oximetry gap (85% saturation despite normal PaO2) is characteristic.\n2.  Standard Treatment: The first-line treatment for symptomatic methemoglobinemia is usually Methylene Blue (Option A). Methylene blue acts as an electron acceptor for the enzyme NADPH-methemoglobin reductase, which reduces methemoglobin back to hemoglobin.\n3.  Contraindication: The reduction of methylene blue requires NADPH. NADPH is generated largely via the Pentose Phosphate Pathway, where G6PD is the rate-limiting enzyme. In patients with G6PD deficiency, there is insufficient NADPH to reduce methylene blue effectively. Furthermore, unreduced methylene blue acts as an oxidant itself and can precipitate severe hemolysis in these patients (\"therapeutic paradox\"). Therefore, Methylene Blue is contraindicated.\n4.  Alternative Treatment: In patients with G6PD deficiency, Ascorbic Acid (Vitamin C) typically serves as the appropriate pharmacological alternative. It reduces methemoglobin to hemoglobin via a non-enzymatic pathway that does not depend on G6PD/NADPH. While its onset of action is slower than methylene blue, it avoids the risk of oxidant-induced hemolysis. For severe, life-threatening cases, exchange transfusion or hyperbaric oxygen therapy might be considered, but for a moderate level (18%) in a stable patient where the primary antidote is contraindicated, Vitamin C is the correct choice.\n    *   Options C (Hydroxocobalamin) and E (Sodium Thiosulfate) are treatments for cyanide poisoning (and calciphylaxis for sodium thiosulfate).\n    *   Option D (Hyperbaric Oxygen) is generally reserved for severe, refractory cases or when the patient is in extremis, which is less likely the first choice for a level of 18% compared to attempting pharmacologic reduction with Vitamin C first.\n\nThe answer is (B)\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-003", "question": "A 31-year-old female presents with amenorrhea 4 months after a full-term delivery. Ultrasound reveals a 4 cm echogenic mass in the myometrium. Serum beta-hCG is 120 IU/L. Immunohistochemistry of a biopsy specimen shows diffuse positivity for human placental lactogen (hPL) and Ki-67 index of 15%. Staging workup is negative for metastasis. What is the treatment of choice?", "options": ["Methotrexate and Folinic Acid", "Actinomycin D", "EMA-CO regimen", "Hysterectomy", "Pembrolizumab"], "answer": "D", "answer_index": 3, "explanation": "The diagnosis is Placental Site Trophoblastic Tumor (PSTT), distinguished from choriocarcinoma by low beta-hCG, strong hPL positivity, and origin from intermediate trophoblasts. Unlike choriocarcinoma, PSTT is relatively resistant to chemotherapy. For localized (Stage I) disease, hysterectomy is the primary and definitive treatment. Chemotherapy is reserved for metastatic or high-risk disease.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "D", "model_outputs": "Based on the clinical presentation and immunohistochemistry findings, the patient has a Placental Site Trophoblastic Tumor (PSTT).\n\n1.  Diagnosis: PSTT is a rare form of Gestational Trophoblastic Disease (GTD) that arises from intermediate trophoblasts at the placental implantation site.\n    *   Key Features:\n        *   Low beta-hCG: Levels are characteristically low (often < 1,000 IU/L) relative to tumor burden, unlike choriocarcinoma which has very high levels.\n        *   Immunohistochemistry: Tumor cells show diffuse positivity for human placental lactogen (hPL). In contrast, choriocarcinoma shows focal hPL positivity and diffuse beta-hCG positivity.\n        *   Ultrasound: Typically shows an echogenic or cystic mass within the myometrium.\n        *   History: It can occur months to years after any type of pregnancy (term delivery, abortion, or molar pregnancy).\n\n2.  Treatment:\n    *   PSTTs are relatively resistant to chemotherapy compared to other GTDs like choriocarcinoma.\n    *   For localized disease (Stage I, confined to the uterus), the treatment of choice is hysterectomy.\n    *   Lymphadenectomy is usually reserved for cases with enlarged lymph nodes or imaging suggestinng nodal involvement, though practice varies. Ovaries can typically be preserved in premenopausal women.\n    *   Chemotherapy (typically platinum-containing regimens like EP/EMA or EMA/CO) is indicated for metastatic disease (Stage II-IV) or high-risk Stage I disease (e.g., long interval since antecedent pregnancy, deep myometrial invasion, or high mitotic count), but surgery remains the cornerstone for localized disease. Single-agent chemotherapy (Options A and B) is ineffective.\n\nTherefore, for a stage I PSTT, hysterectomy is the standard management.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-004", "question": "A 35-year-old male with Myotonic Dystrophy Type 1 presents for emergency appendectomy. Following induction with propofol and succinylcholine, the patient develops generalized muscle rigidity, making ventilation impossible. The heart rate is 110 bpm and temperature is 37.2°C. Which of the following best explains the pathophysiology of this reaction?", "options": ["Uncontrolled calcium release from the sarcoplasmic reticulum via the ryanodine receptor", "Prolonged depolarization of the motor endplate causing sodium channel inactivation failure", "Exaggerated contracture due to sodium channel hyperexcitability distal to the neuromuscular junction", "Denervation hypersensitivity leading to massive potassium efflux", "Deficiency of pseudocholinesterase leading to prolonged blockade"], "answer": "C", "answer_index": 2, "explanation": "This is a succinylcholine-induced myotonic contracture, not Malignant Hyperthermia (MH). In myotonic dystrophy, the muscle membrane is hyperexcitable. Succinylcholine causes a sustained, generalized contracture that acts as a 'chemical splint,' preventing ventilation. Unlike MH, it is not mediated by the RYR1 receptor and does not respond to dantrolene.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "C", "model_outputs": "The clinical scenario describes a patient with Myotonic Dystrophy Type 1 (DM1) who develops generalized muscle rigidity (myotonia) making ventilation impossible following the administration of succinylcholine.\n\n1.  Identification of the Reaction: The reaction described is succinylcholine-induced myotonia. In patients with myotonic syndromes (like DM1 or myotonia congenita), the muscle membrane (sarcolemma) is intrinsically hyperexcitable. DM1 is typically caused by a CTG repeat expansion leading to RNA toxicity that results in aberrant splicing of the ClC-1 chloride channel mRNA. A deficiency in chloride conductance destabilizes the resting membrane potential.\n2.  Mechanism of Succinylcholine Effect: Succinylcholine acts as a depolarizing neuromuscular blocker. In normal muscle, it causes a transient depolarization (fasciculation) followed by relaxation. In myotonic muscle, the initial depolarization by succinylcholine acts as a trigger for the hyperexcitable sarcolemma. Because the membrane potential is unstable (due to low chloride conductance), the sodium channels recover quickly from inactivation or are triggered easily, leading to repetitive firing of action potentials. This results in a sustained, tetanic contraction (myotonia/contracture) of the muscle.\n3.  Distinction from Malignant Hyperthermia (MH): Option A describes the mechanism of MH (uncontrolled Ca2+ release via RyR1). While DM1 patients were historically considered susceptible to MH, modern consensus distinguishes the two. The rigidity in DM1 is a mechanical/electrical contracture of the muscle fiber, not the metabolic catastrophe of RyR1 dysfunction seen in MH, although rhabdomyolysis and hyperkalemia can occur as complications of the severe contraction. The patient's temperature is currently normal, and the primary issue is ventilation difficulty due to chest wall/masseter rigidity.\n4.  Analysis of Option C: \"Exaggerated contracture due to sodium channel hyperexcitability distal to the neuromuscular junction\" accurately describes the pathophysiology. The contraction is a \"contracture\" (sustained contraction) caused by repetitive firing of voltage-gated sodium channels along the muscle membrane (*distal* to the neuromuscular junction). Even though the genetic defect in DM1 is related to chloride channels, the functional outcome is membrane hyperexcitability mediated by sodium channels. The location \"distal to the neuromuscular junction\" is key because non-depolarizing neuromuscular blockers (which act *at* the junction) generally cannot relax this rigidity once it has been triggered.\n\n*   Option A is incorrect because DM1 is not an MH-susceptible condition by definition of RyR1 defects.\n*   Option B is incorrect as it describes a mechanism more akin to desensitization or periodic paralysis but lacks the specific aspect of repetitive firing/contracture characteristic of myotonia.\n*   Option D describes succinylcholine-induced hyperkalemia via upregulated extrajunctional receptors (seen in burns/denervation), which is a different mechanism from the rigidity described.\n*   Option E describes succinylcholine apnea, which presents as flaccid paralysis, not rigidity.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-005", "question": "A 45-year-old female with breast cancer is being treated with tamoxifen. She develops major depressive disorder. Which of the following antidepressants is contraindicated due to a pharmacokinetic interaction that would reduce the oncologic efficacy of her breast cancer treatment?", "options": ["Venlafaxine", "Escitalopram", "Paroxetine", "Desvenlafaxine", "Mirtazapine"], "answer": "C", "answer_index": 2, "explanation": "Tamoxifen is a prodrug that requires conversion to its active metabolite, endoxifen, primarily via the CYP2D6 enzyme. Paroxetine (and fluoxetine) is a potent CYP2D6 inhibitor, which can significantly lower endoxifen levels and potentially increase the risk of breast cancer recurrence. Venlafaxine and escitalopram have minimal effect on CYP2D6.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "C", "model_outputs": "Tamoxifen is a selective estrogen receptor modulator (SERM) used in the treatment of hormone receptor-positive breast cancer. It is a prodrug that is metabolized into its active metabolites (most notably endoxifen) primarily by the cytochrome P450 enzyme CYP2D6.\n\nTherefore, the co-administration of drugs that are strong inhibitors of CYP2D6 can prevent the bioactivation of tamoxifen, leading to subtherapeutic levels of the active metabolite and reduced oncologic efficacy (increased risk of breast cancer recurrence).\n\nLet's evaluate the options based on their effect on CYP2D6:\n*   A. Venlafaxine: A weak inhibitor of CYP2D6. It is often the preferred antidepressant (or treatment for hot flashes) in patients on tamoxifen.\n*   B. Escitalopram: Has weak to negligible inhibitory effects on CYP2D6. Considered a safer option.\n*   C. Paroxetine: A potent inhibitor of CYP2D6. Using paroxetine can significantly lower plasma concentrations of endoxifen. Consequently, it is generally recommended to avoid paroxetine (and fluoxetine, another strong inhibitor) in patients taking tamoxifen.\n*   D. Desvenlafaxine: The active metabolite of venlafaxine; it bypasses CYP2D6 metabolism and does not inhibit the enzyme. Safe to use.\n*   E. Mirtazapine: Does not significantly inhibit CYP2D6. Safe to use.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-006", "question": "A trauma patient presents with a Zone I retroperitoneal hematoma following a high-speed motor vehicle collision. Hemodynamics are transiently stabilized with fluids. CT scan shows the hematoma is centered around the supramesocolic midline. Intraoperatively, what is the mandated management strategy?", "options": ["Observation if the hematoma is not expanding", "Immediate exploration of the hematoma", "Angiographic embolization", "Packing and temporary closure", "REBOA placement in Zone 1"], "answer": "B", "answer_index": 1, "explanation": "Zone I retroperitoneal hematomas (central, midline) in blunt trauma are presumed to involve the aorta, vena cava, or proximal branches (celiac/SMA). Unlike Zone II (flank/kidney) or Zone III (pelvic) hematomas which may be managed non-operatively or with angioembolization if stable, a Zone I hematoma mandates surgical exploration to rule out or repair catastrophic vascular injury.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "This question addresses the surgical management of retroperitoneal hematomas (RPH) classified by the Mattox zones.\n\n1.  Zone Definition:\n    *   Zone I (Central/Medial): Extends from the diaphragmatic hiatus to the sacral promontory. It contains the aorta, inferior vena cava (IVC), pancreas, duodenum, and origins of major visceral vessels (celiac, SMA, renal vessels).\n    *   Zone II (Lateral/Flank): Contains the kidneys, adrenal glands, and ureters.\n    *   Zone III (Pelvic): Contains the iliac vessels, pelvic organs, and presacral plexus.\n\n2.  Management Guidelines by Zone and Mechanism:\n    *   Zone I: Regardless of the mechanism (blunt or penetrating), Zone I hematomas observed during laparotomy mandate immediate surgical exploration. This is because they involve great vessels, and a missed injury here carries a high mortality rate. In this scenario, the hematoma is supramesocolic, implicating the supraceliac aorta, celiac axis, or superior mesenteric artery (SMA). Proximal vascular control (often at the diaphragmatic hiatus) is obtained prior to opening the hematoma.\n    *   Zone II:\n        *   *Penetrating:* Usually requires exploration.\n        *   *Blunt:* Explore only if the hematoma is expanding or pulsatile. If stable, it can often be observed.\n    *   Zone III:\n        *   *Blunt:* Generally do not explore due to the risk of releasing tamponaded bleeding from the presacral venous plexus or pelvic fractures, which is difficult to control surgically. These are managed with pelvic binding and angiography/embolization.\n        *   *Penetrating:* Explore if there is expanding hematoma or loss of pulse.\n\n3.  Application to the Scenario:\n    The patient has a Zone I hematoma stemming from blunt trauma (MVC). Although the patient was \"transiently stabilized,\" the intraoperative finding of a central retroperitoneal hematoma requires opening the retroperitoneum to inspect the major vessels. Standard of care dictates that you cannot rely on observation for Zone I due to the catastrophic consequences of delayed rupture or thrombosis of visceral vessels.\n\n*   A. Observation is incorrect; this applies to stable Zone II (blunt) or Zone III (blunt).\n*   C. Angiographic embolization is the primary treatment for Zone III blunt injuries or specific arterial bleeds identified after damage control, but not the primary management for a Zone I hematoma found during laparotomy.\n*   D. Packing is a damage control adjunct often used for Zone III or diffuse venous oozing (like retrohepatic IVC) but is not the standard mandated management for a general Zone I hematoma, which requires repair of the vessel.\n\nTherefore, the hematoma must be explored.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-007", "question": "A 32-year-old female presents with acute vision loss in the left eye and retrobulbar pain. Examination reveals a central scotoma and an afferent pupillary defect. MRI shows enhancement of the left optic nerve. She is diagnosed with optic neuritis. According to the Optic Neuritis Treatment Trial (ONTT), which treatment regimen is contraindicated because it increases the rate of recurrence?", "options": ["Intravenous methylprednisolone followed by oral prednisone", "Oral prednisone alone", "Intravenous immunoglobulin (IVIG)", "Plasma exchange", "Observation alone"], "answer": "B", "answer_index": 1, "explanation": "The ONTT demonstrated that treatment with oral prednisone alone (at standard doses) not only failed to improve visual outcome compared to placebo but actually significantly increased the rate of recurrent optic neuritis. The standard of care is IV methylprednisolone (often followed by an oral taper) or observation.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "abms_specialty": "Ophthalmology", "abms_source": "target_topic", "source_label_raw": "Ophthalmology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "Based on the Optic Neuritis Treatment Trial (ONTT), patients randomized to the oral prednisone alone group (standard dose, 1 mg/kg/day) had a significantly higher rate of recurrent optic neuritis (in either the affected or contralateral eye) compared to patients treated with intravenous methylprednisolone or placebo.\n\nConsequently, the use of oral prednisone alone in standard doses is generally avoided for the treatment of acute idiopathic optic neuritis. The IV methylprednisolone group (followed by a short course of oral prednisone) showed faster visual recovery but no difference in long-term visual outcome compared to placebo, and it temporarily reduced the risk of developing multiple sclerosis.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-008", "question": "A newborn presents with a unilateral foot deformity where the dorsum of the foot touches the anterior shin. Radiographs reveal 30 degrees of posteromedial bowing of the tibia and fibula. The parents are concerned about the long-term prognosis. Which of the following is the most accurate counseling regarding the natural history of this condition?", "options": ["The bowing will spontaneously resolve, but a leg length discrepancy of 3-4 cm will persist.", "The bowing will progress, requiring osteotomy at age 4.", "The condition is pathognomonic for Neurofibromatosis Type 1 and requires genetic testing.", "The bowing will resolve, but the child will develop a rigid clubfoot deformity.", "The tibia will fracture spontaneously within the first year of life (congenital pseudarthrosis)."], "answer": "A", "answer_index": 0, "explanation": "This is Posteromedial Bowing of the Tibia, a distinct entity from Anterolateral Bowing (associated with NF1 and pseudarthrosis). The bowing spontaneously corrects over time (remodels), but the tibia and fibula remain hypoplastic, leading to a consistent leg length discrepancy (average 3-4 cm) requiring a shoe lift or epiphysiodesis later in life. It is associated with a calcaneovalgus foot, not clubfoot.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "abms_specialty": "Orthopedic Surgery", "abms_source": "target_topic", "source_label_raw": "Orthopedic Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "A", "model_outputs": "Based on the clinical presentation and radiographic findings, the diagnosis is Posteromedial Bowing of the Tibia.\n\n1.  Diagnosis: The combination of a calcaneovalgus foot (dorsum touching the shin) and posteromedial bowing of the tibia constitutes a distinct congenital anomaly. It is distinct from anterolateral bowing, which is associated with Neurofibromatosis Type 1 and Congenital Pseudarthrosis of the Tibia.\n2.  Natural History:\n    *   Bowing: The angular deformity (bowing) has a strong tendency to remodel spontaneously over the first several years of life (typically correcting by age 3-4) due to physiological growth and remodeling.\n    *   Leg Length Discrepancy (LLD): The most characteristic long-term sequela is a leg length discrepancy. The affected tibia grows slower than the contralateral side, resulting in a discrepancy typically ranging from 3 to 4 cm (though it can be more) at skeletal maturity.\n    *   Foot Deformity: The calcaneovalgus foot deformity usually resolves with stretching or serial casting (if severe), but often spontaneously. It does not progress to a rigid clubfoot.\n\nAnalysis of Options:\n*   A: This is correct. The bowing remodels, but the limb remains shorter than the unaffected side.\n*   B: Incorrect. The bowing improves, it does not progress.\n*   C: Incorrect. This refers to anterolateral bowing, which is associated with NF1.\n*   D: Incorrect. The foot is in calcaneus and valgus, not equinus and varus (clubfoot).\n*   E: Incorrect. This refers to anterolateral bowing/Congenital Pseudarthrosis of the Tibia. Posteromedial bowing is benign and does not fracture spontaneously.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-009", "question": "A 55-year-old female is admitted to the ICU with sepsis and severe malnutrition. She has a history of chronic back pain managed with acetaminophen. Arterial blood gas shows pH 7.26, pCO2 28 mmHg, HCO3 12 mEq/L. Serum chemistry shows Na 140, Cl 104, BUN 18, Cr 0.8. Lactate is 1.1 mmol/L. Serum ketones are negative. Measured serum osmolality is 295 mOsm/kg (calculated 290). Which of the following is the most likely etiology of her metabolic acidosis?", "options": ["Methanol intoxication", "D-lactic acidosis", "Pyroglutamic acidosis (5-oxoproline accumulation)", "Propylene glycol toxicity", "Salicylate toxicity"], "answer": "C", "answer_index": 2, "explanation": "The patient has a high anion gap metabolic acidosis (AG = 24) with a normal lactate, no ketones, normal renal function, and a normal osmol gap (ruling out toxic alcohols like methanol or propylene glycol). The combination of chronic acetaminophen use, sepsis, and malnutrition leads to glutathione depletion, causing a disruption in the gamma-glutamyl cycle and accumulation of 5-oxoproline (pyroglutamic acid). This is an under-recognized cause of high anion gap acidosis in this specific patient population.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Critical Care Medicine", "abms_specialty": "Critical Care Medicine", "abms_source": "topics_mapped", "source_label_raw": "critical care", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "C", "model_outputs": "This patient presents with a High Anion Gap Metabolic Acidosis (HAGMA).\nCalculation of Anion Gap: $Na^{+} - (Cl^{-} + HCO_{3}^{-}) = 140 - (104 + 12) = 24$ mEq/L.\n\nLet's evaluate the causes of HAGMA in this patient:\n1.  Lactic Acidosis: The measured lactate is 1.1 mmol/L (normal), identifying that this is not standard L-lactic acidosis.\n2.  Ketoacidosis: Serum ketones are negative, making DKA or starvation ketoacidosis less likely (though beta-hydroxybutyrate is not detected by standard nitroprusside tests, the clinical picture points elsewhere).\n3.  Renal Failure (Uremia): BUN and Creatinine are normal.\n4.  Toxic Alcohols (Methanol, Ethylene Glycol): The calculated osmolar gap is $295 - 290 = 5$ mOsm/kg. Toxic alcohol ingestions typically present with an elevated osmolar gap (>10). There is no history of ingestion.\n5.  Salicylate Toxicity (Option E): While this causes HAGMA and respiratory alkalosis, the history specifies acetaminophen use, not aspirin.\n6.  D-Lactic Acidosis (Option B): This is seen in patients with short bowel syndrome or bacterial overgrowth. Standard lactate assays do not detect D-lactate. However, there is no history of bowel surgery or short gut syndrome.\n7.  Propylene Glycol Toxicity (Option D): Usually iatrogenic (e.g., lorazepam infusions). It often causes an elevated osmolar gap and can result in lactic acidosis. There is no history of such infusions.\n8.  Pyroglutamic Acidosis (5-oxoproline accumulation) (Option C): This condition results from disruption of the gamma-glutamyl cycle. Glutathione creates feedback inhibition on the enzyme gamma-glutamyl cysteine synthetase. In patients with glutathione depletion (due to severe malnutrition and chronic acetaminophen use—which consumes glutathione), this inhibition is lost, leading to the overproduction of 5-oxoproline (pyroglutamic acid).\n    *   This patient has the classic triad of risk factors: Chronic acetaminophen use, Malnutrition, and Critical illness (Sepsis).\n    *   It presents as a HAGMA with normal lactate, negative ketones, and a normal osmolar gap.\n\nGiven the specific history of chronic acetaminophen use and malnutrition in a septic patient with unexplained HAGMA, pyroglutamic acidosis is the most likely etiology.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p01", "question_id": "ABMS20260101_gemini-3-pro-preview_p01-010", "question": "A 68-year-old male presents with a 3-week history of brief, involuntary jerking movements of his right face and arm, occurring up to 40 times per day. He remains conscious during these events. Interictal EEG and brain MRI are unremarkable. He is beginning to show signs of short-term memory impairment. Which of the following is the most appropriate initial treatment?", "options": ["Levetiracetam", "Carbamazepine", "Intravenous Methylprednisolone", "Tissue Plasminogen Activator (tPA)", "Haloperidol"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation is classic for faciobrachial dystonic seizures (FBDS), which are pathognomonic for Anti-LGI1 encephalitis (a form of limbic encephalitis). These seizures are characteristically resistant to standard anti-epileptic drugs but respond dramatically to immunotherapy (steroids, IVIG). Early recognition and treatment with immunotherapy are crucial to prevent the progression to severe cognitive impairment and full-blown limbic encephalitis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "C", "model_outputs": "This patient presents with faciobrachial dystonic seizures (FBDS), characterized by frequent, brief, involuntary jerking movements of the face and ipsilateral arm. These episodes are pathognomonic for anti-LGI1 (leucine-rich glioma-inactivated 1) encephalitis, a form of autoimmune voltage-gated potassium channel (VGKC) complex antibody encephalitis.\n\nKey clinical features in the vignette support this diagnosis:\n1.  Patient Demographics: Older males are commonly affected.\n2.  Symptom Semiologies: The description of brief (<3 seconds), frequent (up to 40-100/day) jerks of the face and arm is the hallmark of FBDS. These are focal seizures.\n3.  Workup: MRI and EEG are often normal initially, or EEG may not capture the brief events/show specific changes.\n4.  Progression: FBDS often precede the onset of memory impairment and full-blown limbic encephalitis. The patient is currently showing signs of memory impairment, suggesting the transition to the encephalitic phase.\n\nTreatment Analysis:\n*   A & B (Antiepileptic Drugs): FBDS are notoriously resistant to standard anti-seizure medications (ASMs). While some reports suggest carbamazepine may be more effective than levetiracetam in reducing seizure frequency, ASMs alone do not treat the underlying autoimmune pathology and often fail to prevent cognitive decline.\n*   C (Intravenous Methylprednisolone): Immunotherapy is the definitive treatment for anti-LGI1 encephalitis. Early initiation of immunotherapy (corticosteroids, IVIG, or plasma exchange) has been shown to result in the cessation of FBDS and, crucially, the prevention or improvement of cognitive deficits. Given the suspected diagnosis and the onset of memory issues, immunotherapy is the most appropriate initial treatment.\n*   D (tPA): This is indicated for acute ischemic stroke. The 3-week history and repetitive nature of the symptoms make a vascular cause incorrect.\n*   E (Haloperidol): This is used for agitation or hyperkinetic movement disorders like chorea, but not for dystonic seizures caused by encephalitis.\n\nTherefore, high-dose corticosteroids are the correct choice to target the underlying autoimmune mechanism.\n\nThe answer is (C)"}]